All News

The NIH announced a clinical trial to evaluate hydroxychloroquine safety and efficacy in patients hospitalized with COVID-19.

The first COVID-19 test to receive approval that does not use invasive cotton swabs to collect patient samples will be available in New Jersey starting Wednesday.

There are now >557 000 confirmed cases of COVID-19 in the US and >21 000 confirmed deaths, the largest amount of any nation to date.

A new study found patients hospitalized with severe complications of COVID-19 demonstrated significant clinical improvement with remdesivir treatment. 

When the face masks are gone, how does care for COVID-19 patients continue? The CDC provides 6 work-arounds to protect HCP.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update. 

COVID-19 can cause heart issues in addition to respiratory distress, according to a team of NYC physicians who provided a closer look with 4 case studies.

Hydroxychloroquine and azithromycin are proposed as treatments for COVID-19 but in patients with existing CV disease could be deadly.

How many cases of COVID-19 have been confirmed globally and nationally? How many recoveries? Get your daily COVID-19 update here.

A state's preparedness to manage the COVID-19 shock to its health system might be assessed by looking at its foundational health care resources.

Authors of a new research letter suggest that although early data show COVID-19 isn't as severe in children, health care providers and caregivers should still be vigilant. 

In Nevada, 14 000 citizens quickly report on COVID-19 signs and symptoms to enhance predictive public health models and inform containtment strategies for the state.

The statistics on COVID-19 signs, symptoms, progression, and spread in China put the world on notice.

ACC.20/WCC. Increased blood levels of eicosapentaenoic acid and not reduced triglycerices may explain reduction in cardiovascular events and death seen in REDUCT-IT study.

For your patients confined to home, whether ill or out of caution, regular virtual contact to check on status and serve as a trusted resource is important. Here are 5 tips on how to do it.

ACC.2020/WCC. The TAILOR-PCI trial found benefit to genotype-guided therapy in first 3 months post-PCI, although 1-year results fell short.

ACC.20/WCC. VICTORIA study shows patients with high-risk heart failure taking vericiguat may have lower risk of CV death, HF hospitalization.

Plan to attend ACC.20/WCC Virtual! The American College of Cardiology virtual 2020 scientfic sessions begin Saturday, March 28, at 8:00 am CDT. Find out how to "attend."